ENVA vs. CORT

In the year-to-date period, ENVA achieves a 14.48% return, which is significantly lower than CORT's 44.08% return. Over the past 10 years, ENVA has underperformed CORT with an annualized return of 16.84%, while CORT has yielded a comparatively higher 36.05% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Enova International, Inc. (ENVA) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ENVA Sharpe Ratio is 2.85, which is lower than the CORT Sharpe Ratio of 4.22. The chart below compares the historical Sharpe Ratios of ENVA and CORT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ENVA nor CORT has paid dividends to shareholders.

The maximum ENVA drawdown since its inception was -81.56%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for ENVA and CORT. For additional features, visit the drawdowns tool.

The current volatility for Enova International, Inc. (ENVA) is 6.78%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 18.97%. This indicates that ENVA experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Enova International, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.